A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. (Q54232269)

From Wikidata
Revision as of 02:47, 30 March 2019 by Emijrpbot (talk | contribs) (‎Updated Item: BOT - Adding descriptions (57 languages): ar, ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
scientific article

    Statements

    title
    A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    19643561
    retrieved
    26 May 2018
    reference URL
    http://europepmc.org/abstract/MED/19643561

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q54232269&oldid=897290258"